In the affected subjects, the disturbance of the leptin-melanocortin pathway led to extreme early-onset obesity as well as metabolic disorders, hypogonadotropic hypogonadism, and suppressed immune function [3–6]. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.